BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32585162)

  • 1. Cholecalciferol abolishes depressive-like behavior and hippocampal glucocorticoid receptor impairment induced by chronic corticosterone administration in mice.
    Camargo A; Dalmagro AP; Platt N; F Rosado A; B Neis V; B Zeni AL; P Kaster M; S Rodrigues AL
    Pharmacol Biochem Behav; 2020 Sep; 196():172971. PubMed ID: 32585162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cholecalciferol on behavior and production of reactive oxygen species in female mice subjected to corticosterone-induced model of depression.
    da Silva Souza SV; da Rosa PB; Neis VB; Moreira JD; Rodrigues ALS; Moretti M
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Jan; 393(1):111-120. PubMed ID: 31463580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholecalciferol counteracts depressive-like behavior and oxidative stress induced by repeated corticosterone treatment in mice.
    Camargo A; Dalmagro AP; Rikel L; da Silva EB; Simão da Silva KAB; Zeni ALB
    Eur J Pharmacol; 2018 Aug; 833():451-461. PubMed ID: 29981295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subthreshold doses of guanosine plus ketamine elicit antidepressant-like effect in a mouse model of depression induced by corticosterone: Role of GR/NF-κB/IDO-1 signaling.
    Camargo A; Dalmagro AP; M Rosa J; B Zeni AL; P Kaster M; Tasca CI; S Rodrigues AL
    Neurochem Int; 2020 Oct; 139():104797. PubMed ID: 32652267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ursolic acid abrogates depressive-like behavior and hippocampal pro-apoptotic imbalance induced by chronic unpredictable stress.
    Colla ARS; Pazini FL; Lieberknecht V; Camargo A; Rodrigues ALS
    Metab Brain Dis; 2021 Mar; 36(3):437-446. PubMed ID: 33394285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emodin opposes chronic unpredictable mild stress induced depressive-like behavior in mice by upregulating the levels of hippocampal glucocorticoid receptor and brain-derived neurotrophic factor.
    Li M; Fu Q; Li Y; Li S; Xue J; Ma S
    Fitoterapia; 2014 Oct; 98():1-10. PubMed ID: 24932776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioural and neuroplastic effects of the new-generation antidepressant agomelatine compared to fluoxetine in glucocorticoid receptor-impaired mice.
    Païzanis E; Renoir T; Lelievre V; Saurini F; Melfort M; Gabriel C; Barden N; Mocaër E; Hamon M; Lanfumey L
    Int J Neuropsychopharmacol; 2010 Jul; 13(6):759-74. PubMed ID: 19775499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant and pro-neurogenic effects of agmatine in a mouse model of stress induced by chronic exposure to corticosterone.
    Olescowicz G; Neis VB; Fraga DB; Rosa PB; Azevedo DP; Melleu FF; Brocardo PS; Gil-Mohapel J; Rodrigues ALS
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():395-407. PubMed ID: 28842257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of serotonergic neurotransmission in the antidepressant-like effect elicited by cholecalciferol in the chronic unpredictable stress model in mice.
    Neis VB; Werle I; Moretti M; Rosa PB; Camargo A; de O Dalsenter Y; Platt N; Rosado AF; Engel WD; de Almeida GRL; Selhorst I; Dafre AL; Rodrigues ALS
    Metab Brain Dis; 2022 Jun; 37(5):1597-1608. PubMed ID: 35435610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single administration of agmatine reverses the depressive-like behavior induced by corticosterone in mice: Comparison with ketamine and fluoxetine.
    Neis VB; Bettio LB; Moretti M; Rosa PB; Olescowicz G; Fraga DB; Gonçalves FM; Freitas AE; Heinrich IA; Lopes MW; Leal RB; Rodrigues ALS
    Pharmacol Biochem Behav; 2018 Oct; 173():44-50. PubMed ID: 30125592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender-specific effects of fluoxetine on hippocampal glucocorticoid receptor phosphorylation and behavior in chronically stressed rats.
    Mitic M; Simic I; Djordjevic J; Radojcic MB; Adzic M
    Neuropharmacology; 2013 Jul; 70():100-11. PubMed ID: 23353902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mineralocorticoid receptor antagonist spironolactone prevents chronic corticosterone induced depression-like behavior.
    Wu TC; Chen HT; Chang HY; Yang CY; Hsiao MC; Cheng ML; Chen JC
    Psychoneuroendocrinology; 2013 Jun; 38(6):871-83. PubMed ID: 23044404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketamine, but not guanosine, as a prophylactic agent against corticosterone-induced depressive-like behavior: Possible role of long-lasting pro-synaptogenic signaling pathway.
    Camargo A; Dalmagro AP; de Souza MM; Zeni ALB; Rodrigues ALS
    Exp Neurol; 2020 Dec; 334():113459. PubMed ID: 32891670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low doses of ketamine and guanosine abrogate corticosterone-induced anxiety-related behavior, but not disturbances in the hippocampal NLRP3 inflammasome pathway.
    Camargo A; Dalmagro AP; Fraga DB; Rosa JM; Zeni ALB; Kaster MP; Rodrigues ALS
    Psychopharmacology (Berl); 2021 Sep; 238(9):2555-2568. PubMed ID: 34342672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant effects of creatine on amyloid β
    Rosa JM; Pazini FL; Cunha MP; Colla ARS; Manosso LM; Mancini G; Souza ACG; de Bem AF; Prediger RD; Rodrigues ALS
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():270-278. PubMed ID: 29753049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Creatine Prevents Corticosterone-Induced Reduction in Hippocampal Proliferation and Differentiation: Possible Implication for Its Antidepressant Effect.
    Pazini FL; Cunha MP; Azevedo D; Rosa JM; Colla A; de Oliveira J; Ramos-Hryb AB; Brocardo PS; Gil-Mohapel J; Rodrigues ALS
    Mol Neurobiol; 2017 Oct; 54(8):6245-6260. PubMed ID: 27714631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ascorbic acid treatment, similarly to fluoxetine, reverses depressive-like behavior and brain oxidative damage induced by chronic unpredictable stress.
    Moretti M; Colla A; de Oliveira Balen G; dos Santos DB; Budni J; de Freitas AE; Farina M; Severo Rodrigues AL
    J Psychiatr Res; 2012 Mar; 46(3):331-40. PubMed ID: 22154133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A low-dose combination of ketamine and guanosine counteracts corticosterone-induced depressive-like behavior and hippocampal synaptic impairments via mTORC1 signaling.
    Camargo A; Dalmagro AP; Wolin IAV; Siteneski A; Zeni ALB; Rodrigues ALS
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Dec; 111():110371. PubMed ID: 34089815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid prevents depressive-like behavior induced by chronic corticosterone treatment in mice.
    Rosa PB; Ribeiro CM; Bettio LE; Colla A; Lieberknecht V; Moretti M; Rodrigues AL
    Pharmacol Biochem Behav; 2014 Dec; 127():1-6. PubMed ID: 25316305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary Co-supplements attenuate the chronic unpredictable mild stress-induced depression in mice.
    Sirasangi MI; Roohi TF; Krishna KL; Kinattingal N; Wani SUD; Mehdi S
    Behav Brain Res; 2024 Feb; 459():114788. PubMed ID: 38036263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.